Panel-based pharmacogenetic genotyping for Pharmacogenetic Testing

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UF Health at the University of Florida, Gainesville, FLPharmacogenetic TestingPanel-based pharmacogenetic genotyping - DiagnosticTest
Eligibility
18 - 99
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether panel-based pharmacogenetic testing leads to improved medication satisfaction for black and Latino patients.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12-14 months

12-14 months
Change in Patient Treatment Satisfaction Measured by the Treatment Satisfaction Questionnaire for Medication (TSQM)

Trial Safety

Trial Design

1 Treatment Group

Panel-based pharmacogenetic genotyping
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Panel-based pharmacogenetic genotyping · No Placebo Group · N/A

Panel-based pharmacogenetic genotyping
DiagnosticTest
Experimental Group · 1 Intervention: Panel-based pharmacogenetic genotyping · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12-14 months

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
39,795 Total Patients Enrolled
University of FloridaLead Sponsor
1,261 Previous Clinical Trials
699,340 Total Patients Enrolled
1 Trials studying Pharmacogenetic Testing
492 Patients Enrolled for Pharmacogenetic Testing
National Center for Advancing Translational Sciences (NCATS)NIH
199 Previous Clinical Trials
355,854 Total Patients Enrolled
Julio Duarte, PharmD, PhDPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
503 Total Patients Enrolled
1 Trials studying Pharmacogenetic Testing
492 Patients Enrolled for Pharmacogenetic Testing

Eligibility Criteria

Age 18 - 99 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You identify yourself as a person of Black or Latino ethnicity.

Frequently Asked Questions

What is the uppermost limit for participant enrollment in this clinical experiment?

"That is correct. Clinicaltrials.gov notes that this clinical trial, which was initially posted on May 13th 2021, is actively enrolling participants. This study requires 100 people to join from a single medical centre." - Anonymous Online Contributor

Unverified Answer

Does my profile qualify me to participate in this investigation?

"This research trial is open to 100 individuals aged 18-99 with a recent pharmacogenetic test. Other inclusion requirements include: evidence of medication adjustment within the past 6 months, and self-identifying as either Black or Latinx." - Anonymous Online Contributor

Unverified Answer

Are new participants still being accepted into this research?

"Affirmative. Clinicaltrials.gov confirms that recruitment is open for this medical project, which was first posted on May 13th 2021 and has since been revised on June 28th 2022. The trial seeks 100 applicants from one particular clinical site." - Anonymous Online Contributor

Unverified Answer

Does the study accept participants younger than 80 years of age?

"In order to be accepted into this clinical trial, individuals must meet the age requirements. These are a minimum of 18 years and a maximum of 99 years old." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.